XBIOTECH INC. Operating Cash Flow
XBIOTECH INC. (XBIT) reported Operating Cash Flow of -$13.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- XBIOTECH INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.51M.
- XBIOTECH INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.97M.
- XBIOTECH INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$22.95M.
- XBIOTECH INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.26M.
- XBIOTECH INC. net cash provided by (used in) operating activities for fiscal 2025 was -$39.92M.
- XBIOTECH INC. net cash provided by (used in) operating activities for fiscal 2024 was -$30.96M.
- XBIOTECH INC. net cash provided by (used in) operating activities for fiscal 2023 was -$18.73M.
- XBIOTECH INC. net cash provided by (used in) operating activities for fiscal 2022 was -$14.82M, a 121.35% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$13.48M 10-Q · filed 2026-08-13 | -$36.44M derived: sum of 3 quarters · filed 2026-08-13 | -$40.70M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$8.97M 10-Q · filed 2026-05-14 | -$31.92M derived: sum of 2 quarters · filed 2026-05-14 | -$36.18M derived: sum of 3 quarters · filed 2026-05-14 | -$42.17M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$27.21M derived: sum of 2 quarters · filed 2026-03-13 | -$33.20M derived: sum of 3 quarters · filed 2026-08-13 | -$39.92M 10-K · filed 2026-03-13 | ||
| 2025-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$10.25M derived: sum of 2 quarters · filed 2026-08-13 | -$16.97M 10-Q · filed 2025-11-12 | -$23.51M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$12.71M 10-Q · filed 2026-08-13 | -$19.25M derived: sum of 3 quarters · filed 2026-08-13 | -$25.09M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$6.72M 10-Q · filed 2026-05-14 | -$13.26M derived: sum of 2 quarters · filed 2026-05-14 | -$19.11M derived: sum of 3 quarters · filed 2026-05-14 | -$30.48M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$12.38M derived: sum of 2 quarters · filed 2026-03-13 | -$23.76M derived: sum of 3 quarters · filed 2026-03-13 | -$30.96M 10-K · filed 2026-03-13 | ||
| 2024-09-30 | -$5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$17.22M derived: sum of 2 quarters · filed 2025-11-12 | -$24.42M 10-Q · filed 2025-11-12 | -$27.86M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$11.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$18.58M 10-Q · filed 2025-08-13 | -$22.01M derived: sum of 3 quarters · filed 2025-08-13 | -$23.50M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | -$7.20M 10-Q · filed 2025-05-14 | -$10.63M derived: sum of 2 quarters · filed 2025-05-14 | -$12.12M derived: sum of 3 quarters · filed 2025-05-14 | -$21.12M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$4.92M derived: sum of 2 quarters · filed 2025-03-18 | -$13.92M derived: sum of 3 quarters · filed 2025-03-18 | -$18.73M 10-K · filed 2025-03-18 | ||
| 2023-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$10.48M derived: sum of 2 quarters · filed 2024-11-13 | -$15.29M 10-Q · filed 2024-11-13 | -$18.46M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$13.80M 10-Q · filed 2024-08-12 | -$16.97M derived: sum of 3 quarters · filed 2024-08-12 | -$18.12M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$4.81M 10-Q · filed 2024-05-10 | -$7.97M derived: sum of 2 quarters · filed 2024-05-10 | -$9.12M derived: sum of 3 quarters · filed 2024-05-10 | -$14.51M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$4.31M derived: sum of 2 quarters · filed 2024-03-15 | -$9.70M derived: sum of 3 quarters · filed 2024-03-15 | -$14.82M 10-K · filed 2024-03-15 | ||
| 2022-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$6.54M derived: sum of 2 quarters · filed 2023-11-09 | -$11.66M 10-Q · filed 2023-11-09 | -$17.53M 10-Q · filed 2022-11-09 | -$13.42M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$5.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$10.51M 10-Q · filed 2023-08-11 | -$11.50M 10-Q · filed 2022-08-10 | -$12.27M derived: sum of 3 quarters · filed 2023-08-11 | -$15.67M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$5.12M 10-Q · filed 2023-05-10 | -$6.88M derived: sum of 2 quarters · filed 2023-05-10 | -$10.28M derived: sum of 3 quarters · filed 2023-05-10 | $62.51M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$5.16M derived: sum of 2 quarters · filed 2023-03-15 | $67.64M derived: sum of 3 quarters · filed 2023-03-15 | $69.44M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | -$3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $69.39M derived: sum of 2 quarters · filed 2022-11-09 | $71.20M 10-Q · filed 2022-11-09 | $70.81M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $72.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $74.61M 10-Q · filed 2022-08-10 | $74.22M derived: sum of 3 quarters · filed 2022-08-10 | $81.70M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $1.81M 10-Q · filed 2022-05-10 | $1.42M derived: sum of 2 quarters · filed 2022-05-10 | $8.90M derived: sum of 3 quarters · filed 2022-05-10 | -$2.67M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $7.09M derived: sum of 2 quarters · filed 2022-03-15 | -$4.48M derived: sum of 3 quarters · filed 2022-03-15 | -$65.15M 10-K · filed 2022-03-15 | ||
| 2020-09-30 | $7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$4.08M derived: sum of 2 quarters · filed 2021-11-09 | -$64.76M 10-Q · filed 2021-11-09 | -$68.50M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-06-30 | -$11.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$72.24M 10-Q · filed 2021-08-09 | -$75.99M derived: sum of 3 quarters · filed 2022-03-15 | -$80.97M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-03-31 | -$60.67M 10-Q · filed 2021-05-10 | -$64.42M derived: sum of 2 quarters · filed 2022-03-15 | -$69.40M derived: sum of 3 quarters · filed 2022-03-15 | -$74.27M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2019-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$8.73M derived: sum of 2 quarters · filed 2022-03-15 | -$13.59M derived: sum of 3 quarters · filed 2022-03-15 | -$18.27M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | -$4.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$9.85M derived: sum of 2 quarters · filed 2020-11-09 | -$14.52M 10-Q · filed 2020-11-09 | -$19.64M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | -$4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$9.54M 10-Q · filed 2020-08-10 | -$14.66M derived: sum of 3 quarters · filed 2021-03-16 | -$18.65M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | -$4.68M 10-Q · filed 2020-05-11 | -$9.79M derived: sum of 2 quarters · filed 2021-03-16 | -$13.79M derived: sum of 3 quarters · filed 2021-03-16 | -$17.69M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2018-12-31 | -$5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$9.11M derived: sum of 2 quarters · filed 2021-03-16 | -$13.01M derived: sum of 3 quarters · filed 2021-03-16 | -$16.54M 10-K · filed 2021-03-16 | ||
| 2018-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$7.89M derived: sum of 2 quarters · filed 2019-11-12 | -$11.42M 10-Q · filed 2019-11-12 | -$18.23M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$7.43M 10-Q · filed 2019-08-09 | -$14.23M derived: sum of 3 quarters · filed 2020-03-16 | -$20.70M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-03-31 | -$3.53M 10-Q · filed 2019-05-09 | -$10.33M derived: sum of 2 quarters · filed 2020-03-16 | -$16.80M derived: sum of 3 quarters · filed 2020-03-16 | -$25.27M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2017-12-31 | -$6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$13.27M derived: sum of 2 quarters · filed 2020-03-16 | -$21.74M derived: sum of 3 quarters · filed 2020-03-16 | -$33.65M 10-K · filed 2020-03-16 | ||
| 2017-09-30 | -$6.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$14.93M derived: sum of 2 quarters · filed 2018-10-31 | -$26.84M 10-Q · filed 2018-10-31 | -$39.64M derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2017-06-30 | -$8.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$20.38M 10-Q · filed 2018-08-09 | -$33.18M derived: sum of 3 quarters · filed 2019-03-15 | -$48.19M derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2017-03-31 | -$11.91M 10-Q · filed 2018-05-08 | -$24.71M derived: sum of 2 quarters · filed 2019-03-15 | -$39.73M derived: sum of 3 quarters · filed 2019-03-15 | -$47.98M derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2016-12-31 | -$12.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$27.82M derived: sum of 2 quarters · filed 2019-03-15 | -$36.07M derived: sum of 3 quarters · filed 2019-03-15 | -$46.02M 10-K/A · filed 2019-03-15 | ||
| 2016-09-30 | -$15.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$23.27M derived: sum of 2 quarters · filed 2017-11-09 | -$33.21M 10-Q · filed 2017-11-09 | -$43.91M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | -$8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$18.20M 10-Q · filed 2016-08-12 | -$28.89M derived: sum of 3 quarters · filed 2018-03-16 | -$36.11M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | -$9.95M 10-Q · filed 2017-05-10 | -$20.64M derived: sum of 2 quarters · filed 2018-03-16 | -$27.86M derived: sum of 3 quarters · filed 2018-03-16 | -$36.72M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$17.91M derived: sum of 2 quarters · filed 2018-03-16 | -$26.78M derived: sum of 3 quarters · filed 2018-03-16 | -$33.31M 10-K · filed 2018-03-16 | ||
| 2015-09-30 | -$7.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$16.08M derived: sum of 2 quarters · filed 2016-11-14 | -$22.61M 10-Q · filed 2016-11-14 | -$26.06M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$8.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$15.39M 10-Q · filed 2016-08-12 | -$18.84M derived: sum of 3 quarters · filed 2017-03-16 | -$22.07M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | -$6.53M 10-Q · filed 2016-05-13 | -$9.98M derived: sum of 2 quarters · filed 2017-03-16 | -$13.21M derived: sum of 3 quarters · filed 2017-03-16 | -$15.89M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | -$3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$6.68M derived: sum of 2 quarters · filed 2017-03-16 | -$9.36M derived: sum of 3 quarters · filed 2017-03-16 | -$11.70M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$5.91M derived: sum of 2 quarters · filed 2015-11-13 | -$8.25M 10-Q · filed 2015-11-13 | |||
| 2014-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$5.02M 10-Q · filed 2015-08-14 | ||||
| 2014-03-31 | -$2.34M 10-Q · filed 2015-06-18 | |||||
| 2013-12-31 | -$8.91M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |